• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盖尔模型在三个初级保健专科中的应用及乳腺癌预防性治疗

Use of the Gail model and breast cancer preventive therapy among three primary care specialties.

作者信息

Corbelli Jennifer, Borrero Sonya, Bonnema Rachel, McNamara Megan, Kraemer Kevin, Rubio Doris, Karpov Irina, McNeil Melissa

机构信息

1 Division of General Internal Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania.

出版信息

J Womens Health (Larchmt). 2014 Sep;23(9):746-52. doi: 10.1089/jwh.2014.4742. Epub 2014 Aug 12.

DOI:10.1089/jwh.2014.4742
PMID:25115368
Abstract

BACKGROUND

Breast cancer is an issue of serious concern among women of all ages. The extent to which providers across primary care specialties assess breast cancer risk and discuss chemoprevention is unknown.

METHODS

Cross-sectional web-based survey completed by 316 physicians in internal medicine (IM), family medicine (FM), and gynecology (GYN) from February to April of 2012. Survey items assessed respondents' frequency of use of the Gail model and chemoprevention, and their attitudes behind practice patterns. Descriptive statistics were used to generate response distributions, and chi-squared tests were used to compare responses among specialties.

RESULTS

The response rate was 55.0 % (316/575). Only 40% of providers report having used the Gail model (37% IM, 33% FM, 60% GYN) and 13% report having recommended or prescribed chemoprevention (9% IM, 8% FM, 30% GYN). Among providers who use the Gail model, a minority use it regularly in patients who may be at increased breast cancer risk. Among providers who have prescribed chemoprevention, most have done so five times or fewer. Lack of both time and familiarity were commonly cited barriers to use of the Gail score and chemoprevention.

CONCLUSIONS

An overall minority of providers, most notably in FM and IM, use the Gail model to assess, and chemoprevention to decrease, breast cancer risk. Until providers are more consistent in their use of the Gail model (or other breast cancer risk calculator) and chemoprevention, opportunities to intervene in women at increased risk will likely continue to be missed.

摘要

背景

乳腺癌是所有年龄段女性都严重关注的问题。各初级保健专科的医疗服务提供者评估乳腺癌风险并讨论化学预防的程度尚不清楚。

方法

2012年2月至4月,316名内科(IM)、家庭医学(FM)和妇科(GYN)医生完成了基于网络的横断面调查。调查项目评估了受访者使用盖尔模型和化学预防的频率,以及他们实践模式背后的态度。描述性统计用于生成应答分布,卡方检验用于比较各专科之间的应答。

结果

应答率为55.0%(316/575)。只有40%的医疗服务提供者报告使用过盖尔模型(内科37%,家庭医学33%,妇科60%),13%的医疗服务提供者报告曾推荐或开出处方进行化学预防(内科9%,家庭医学8%,妇科30%)。在使用盖尔模型的医疗服务提供者中,少数人会在乳腺癌风险可能增加的患者中定期使用该模型。在开出处方进行化学预防的医疗服务提供者中,大多数人这样做的次数为五次或更少。时间不足和不熟悉通常被认为是使用盖尔评分和化学预防的障碍。

结论

总体而言,少数医疗服务提供者,尤其是家庭医学和内科的医疗服务提供者,使用盖尔模型进行评估,并使用化学预防来降低乳腺癌风险。在医疗服务提供者更一致地使用盖尔模型(或其他乳腺癌风险计算器)和化学预防之前,干预乳腺癌风险增加女性的机会可能会继续被错过。

相似文献

1
Use of the Gail model and breast cancer preventive therapy among three primary care specialties.盖尔模型在三个初级保健专科中的应用及乳腺癌预防性治疗
J Womens Health (Larchmt). 2014 Sep;23(9):746-52. doi: 10.1089/jwh.2014.4742. Epub 2014 Aug 12.
2
Physician adherence to U.S. Preventive Services Task Force mammography guidelines.医生对美国预防服务工作组乳腺 X 线摄影指南的依从性。
Womens Health Issues. 2014 May-Jun;24(3):e313-9. doi: 10.1016/j.whi.2014.03.003.
3
Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.初级保健医生对 2009 年美国妇产科医师学会宫颈癌筛查指南的依从性存在差异。
J Womens Health (Larchmt). 2014 May;23(5):397-403. doi: 10.1089/jwh.2013.4475. Epub 2013 Dec 31.
4
The Gail Model and Its Use in Preventive Screening: A Comparison of the Corbelli Study.盖尔模型及其在预防性筛查中的应用:科尔贝利研究的比较
Cureus. 2024 Mar 16;16(3):e56290. doi: 10.7759/cureus.56290. eCollection 2024 Mar.
5
Women's views on chemoprevention of breast cancer: qualitative study.女性对乳腺癌化学预防的看法:定性研究
Can Fam Physician. 2006 May;52(5):624-5.
6
Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.基层医疗中乳腺癌风险评估与管理:医疗服务提供者的态度、实践及障碍
Cancer Detect Prev. 2007;31(5):375-83. doi: 10.1016/j.cdp.2007.08.003. Epub 2007 Nov 26.
7
Breast Cancer Risk Assessment and Chemoprevention Use Among Veterans Affairs Primary Care Providers: A National Online Survey.退伍军人事务部初级保健提供者中乳腺癌风险评估和化学预防用药的使用:一项全国性在线调查。
Mil Med. 2020 Mar 2;185(3-4):512-518. doi: 10.1093/milmed/usz291.
8
Discontent and Confusion: Primary Care Providers' Opinions and Understanding of Current Cervical Cancer Screening Recommendations.不满与困惑:初级保健提供者对当前宫颈癌筛查建议的看法与理解
J Womens Health (Larchmt). 2016 Mar;25(3):255-62. doi: 10.1089/jwh.2015.5326. Epub 2015 Nov 5.
9
Emergency contraception provision: a survey of Michigan physicians from five medical specialties.紧急避孕措施的提供:对密歇根州五个医学专业医生的一项调查。
J Womens Health (Larchmt). 2007 May;16(4):489-98. doi: 10.1089/jwh.2006.0196.
10
Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners.妇产科医生和执业护士的结直肠癌筛查实践
J Womens Health (Larchmt). 2009 Aug;18(8):1233-8. doi: 10.1089/jwh.2008.1117.

引用本文的文献

1
Use of breast cancer risk reducing medications by breast cancer risk level in an older U.S. cohort.美国一个老年队列中按乳腺癌风险水平使用降低乳腺癌风险药物的情况。
Cancer Epidemiol. 2025 Aug;97:102856. doi: 10.1016/j.canep.2025.102856. Epub 2025 May 31.
2
Validation study of risk-reduction activities after personalized breast cancer education tool in the WISDOM study.WISDOM研究中个性化乳腺癌教育工具后风险降低活动的验证研究。
NPJ Breast Cancer. 2024 Oct 14;10(1):90. doi: 10.1038/s41523-024-00681-z.
3
Implementation of risk assessment process for breast cancer risk in primary care.
在初级保健中实施乳腺癌风险评估流程
J Cancer Prev Curr Res. 2024;15(3):65-69. doi: 10.15406/jcpcr.2024.15.00552. Epub 2024 Jun 28.
4
Impact of Affordable Care Act Provisions on the Racial Makeup of Patients Enrolled at a Deep South, High-Risk Breast Cancer Clinic.《平价医疗法案》条款对美国最南部一家高风险乳腺癌诊所登记患者种族构成的影响
J Racial Ethn Health Disparities. 2024 Sep 5. doi: 10.1007/s40615-024-02104-y.
5
The Gail Model and Its Use in Preventive Screening: A Comparison of the Corbelli Study.盖尔模型及其在预防性筛查中的应用:科尔贝利研究的比较
Cureus. 2024 Mar 16;16(3):e56290. doi: 10.7759/cureus.56290. eCollection 2024 Mar.
6
A Scoping Review of Personalized, Interactive, Web-Based Clinical Decision Tools Available for Breast Cancer Prevention and Screening in the United States.美国可用于乳腺癌预防和筛查的个性化、交互式、基于网络的临床决策工具的范围综述
MDM Policy Pract. 2024 Mar 17;9(1):23814683241236511. doi: 10.1177/23814683241236511. eCollection 2024 Jan-Jun.
7
Talking numbers: how women and providers use risk scores during and after risk counseling - a qualitative investigation from the NRG Oncology/NSABP DMP-1 study.谈数字:女性和提供者如何在风险咨询期间和之后使用风险评分 - NRG 肿瘤学/ NSABP DMP-1 研究的定性调查。
BMJ Open. 2023 Nov 19;13(11):e073138. doi: 10.1136/bmjopen-2023-073138.
8
Impact of Affordable Care Act provisions on the racial makeup of patients enrolled at a Deep South, high-risk breast cancer clinic.《平价医疗法案》条款对美国最南部一家高风险乳腺癌诊所登记患者种族构成的影响
Res Sq. 2023 Oct 24:rs.3.rs-3359906. doi: 10.21203/rs.3.rs-3359906/v1.
9
Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST).队列简介:中国结直肠癌、乳腺癌、肺癌、肝癌和胃癌筛查试验(C-BLAST)的设计与方法
Cancer Biol Med. 2023 Oct 27;20(10):713-20. doi: 10.20892/j.issn.2095-3941.2023.0278.
10
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study.WISDOM研究中高危女性接触个性化乳腺癌风险评估教育工具后风险降低活动的验证研究
Res Sq. 2023 May 10:rs.3.rs-2787493. doi: 10.21203/rs.3.rs-2787493/v1.